Xenophon PCDGS
Veteran Member
Has any one any thoughts on what repercussions to jobs in Britain there might be should this occur ?

Pfizer have a fair amount of experience to do with drugs that help with producing Siemenscan't Siemens step in![]()
AstraZeneca is a listed company and so its shares can be bought by anyone. I live in the UK but yet hold shares in nominally 'American' companies. The shareholders, as with any big listed company, are predominately owned by financial institutions. It is not as if it is a family run business.
If AstraZeneca didn't want to be bought out by foreigners, they shouldn't have gone public in the first place. It isn't even a proper British company, given that it merged with a Swedish company not very long ago. The 'Zeneca' bit comes from ICI, which, again, was listed.
Final bid of £69.4bn made by Pfizer
http://www.theguardian.com/business...inal-astrazeneca-takeover-proposal?CMP=twt_fd
AstraZeneca has rejected US rival Pfizer's "final offer" takeover bid, which valued the company at £69.3bn.
The British drug giant said the offer of £55 a share falls short of its value as an independent company and that Pfizer had failed to "make a compelling strategic business or value case".
http://news.sky.com/story/1264321/astrazeneca-rejects-pfizer-final-offer
I doubt that this is the end of this. I read this morning that Boots is also on the verge of takeover by Walgreens the famous American drug store chain.
Expect a bid of £67-70bn to test the resolve of the directors and shareholders
Fund manager Schroders wants AstraZeneca to "recommence engagement" with Pfizer, after the UK drug maker rejected a takeover by its US rival.
UK-based Schroders is the twelfth largest shareholder in AstraZeneca, with a 2% holding.
On Monday, AstraZeneca rejected a £55 per share bid from Pfizer, who said the proposal would be its final offer.
AstraZeneca said this undervalued the company and the takeover is viewed as highly unlikely at this stage.
'Quick rejection'
In a statement Schroders said it "would encourage the AstraZeneca management to recommence their engagement with Pfizer and subsequently their shareholders".
It continued: "Schroders notes with disappointment the quick rejection by the AstraZeneca board of the latest offer from Pfizer, and the decision of the Pfizer board to draw a premature end to these negotiations by calling their latest proposal final."
Schroders joins other shareholders such as Axa Investments and Jupiter Fund Management in expressing disappointment at the AstraZeneca decision not to speak in greater detail to its shareholders.
Well, it just goes to show that the City cannot be trusted to act in the strategic interests of the Country. Will our supine politicians finally introduce a public interest test for these sorts of occasions, or will it all be quietly forgotten about until the next time.